Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 5/20 | 0.48 |
| ▸ | CA2 | P00918 | 5/20 | 0.48 |
| ▸ | CA9 | Q16790 | 5/20 | 0.48 |
| ▸ | CA5A | P35218 | 2/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.48 |
| ▸ | S100B | P04271 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18130076 | 0.87 | APP (0.47) | TP53CA1CA2CA9CA5A | |
| SCHEMBL18130122 | 0.87 | NQO2 (0.48) | TP53CA1CA2CA9CA5A | |
| SCHEMBL18130123 | 0.87 | NQO2 (0.48) | TP53CA1CA2CA9CA5A | |
| SCHEMBL16748959 | 0.86 | CA1 (0.58) | TP53CA1CA2CA9CA5A | |
| SCHEMBL13667432 | 0.78 | CA1 (0.52) | TP53CA1CA2CA9CA5A | |
| SCHEMBL13667405 | 0.78 | CA1 (0.52) | TP53CA1CA2CA9CA5A | |
| SCHEMBL15845029 | 0.78 | CA1 (0.52) | TP53CA1CA2CA9CA5A | |
| Hydrochloric Acid SCHEMBL28769370 | 0.76 | CA1 (0.50) | TP53CA1CA2CA9CA5A | |
| SCHEMBL31574334 | 0.76 | BACE1 (0.44) | TP53CA1CA2CA9CA5A | |
| SCHEMBL25202043 | 0.75 | F3 (0.68) | MEN1KMT2AALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106674212-B | Thiophene triazole wave draws (Bola) compound | 云南大学 | 2019-08-09 | — | — | CN | claimed |
| CN-106674212-A | Thiophene triazole bola (Bola) compound | 云南大学 | 2017-05-17 | — | — | CN | claimed |
| CN-106632271-A | Erlotinib derivative with antitumor activity, and preparation method and application thereof | 河南师范大学 | 2017-05-10 | — | — | CN | claimed |
| CN-103059010-B | Isosorbide-5-Nitrae-benzoxazinone-1,2,3-triazole compound with anti-mycotic activity and preparation method thereof | HENAN NORMAL UNIVERSITY (CN) | 2015-09-02 | — | — | CN | claimed |
| CN-103288885-B | Synthesis method of mono-substituted ferrocene ramification containing 1,2,3-triazole heterocycle | UNIV INNER MONGOLIA | 2015-03-11 | — | — | CN | claimed |
| CN-103288885-A | Synthesis method of mono-substituted ferrocene ramification containing 1,2,3-triazole heterocycle | UNIV INNER MONGOLIA | 2013-09-11 | — | — | CN | claimed |
| US-12617905-B2 | Crosslinked alginic acid | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4651903-A1 | M6PR BINDING COMPOUNDS AND CONJUGATES | Lycia Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4605009-A2 | GLYCAN CONJUGATE COMPOSITIONS AND METHODS | GanNA Bio, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12378204-B2 | Triazole compounds and preparation method therefor and use thereof | WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) | 2025-08-05 | — | — | US | disclosed |
| WO-2025136932-A1 | INTRACELLULAR LIGATION OF PHOTOCATALYSTS FOR PHOTO-RESPONSIVE, PROBE-MEDIATED PROTEIN LABELING | SEED THERAPEUTICS US, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| US-12147158-B2 | Photocurable composition and method for producing semiconductor device | NISSAN CHEMICAL CORPORATION (JP) | 2024-11-19 | — | — | US | disclosed |
| US-20240342340-A1 | MULTILAYER STRUCTURE USING CHEMICALLY CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2024-10-17 | — | — | US | disclosed |
| US-20080188638-A1 | Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof | INTEZYNE TECHNOLOGIES (US) | 2008-08-07 | — | — | US | disclosed |
| US-20080188638-A1 | Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof | INTEZYNE TECHNOLOGIES (US) | 2008-08-07 | — | — | US | disclosed |
| CN-101076880-A | Method and device for forming monolayer nanostructures and device comprising such monolayer | NANOSYS INC (US) | 2007-11-21 | — | — | CN | disclosed |
| WO-2007127440-A2 | HETEROFUNCTIONAL POLY(ETHYLENE GLYCOL) CONTAINING ACID-LABILE AMINO PROTECTING GROUPS AND USES THEREOF | INTEZYNE TECHNOLOGIES, INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| WO-2007127473-A2 | POLY (ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS | INTEZYNE TECHNOLOGIES, INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| CN-1042345-C | Gasoline compositions | SHELL INT RESEARCH (NL) | 1999-03-03 | — | — | CN | disclosed |
| CN-1083853-A | Gasoline composition | SHELL INT RESEARCH (NL) | 1994-03-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188638-A1 | Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof | LNPEP, GNE, DNPEP | TP53 818/4885CA1 793/4885CA2 2008/4885 |
| US-12378204-B2 | Triazole compounds and preparation method therefor and use thereof | LPAR1, LPAR3, FFAR1 | TP53 2002/4885CA1 4806/4885CA2 4801/4885 |
| US-12617905-B2 | Crosslinked alginic acid | ALG1, ANXA6, HEXB | TP53 4010/4885CA1 652/4885CA2 1361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.